TCTMD's Avatar

TCTMD

@tctmd.bsky.social

Your source for breaking news, topical videos, and slides covering cardiovascular disease and interventions. Register at http://tctmd.com

969 Followers  |  112 Following  |  1,412 Posts  |  Joined: 20.11.2024  |  1.6499

Latest posts by tctmd.bsky.social on Bluesky


Preview
AHA/ACC Guideline Tackles Evidence-Based Acute PE Care AHA/ACC Guideline Tackles Evidence-Based Acute PE Care cmacahilig@crf.org Thu, 02/19/2026 - 16:36 L.A. McKeown A highlight of the document is a new severity clinical category system to account for phenotypes and respiratory issues.

AHA/ACC Guideline Tackles Evidence-Based Acute PE Care

19.02.2026 21:44 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Both Low-fat and Low-carb Diets Tied to Less Heart Disease There’s a lot of nuance in the numbers, thoughβ€”only diets with a lot of healthy, nutrient-dense foods came out as winners.

A low-fat and low-carb diet that is rich in plant-based foods, whole grains, and unsaturated fats is linked to lower risk of coronary heart disease, according to the results of a new study. More here: www.tctmd.com/news/both-lo...

19.02.2026 20:03 β€” πŸ‘ 3    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Video thumbnail

The first ever European Association of Percutaneous Cardiovascular Interventions (EAPCI) Summit has begun in Munich, Germany! Watch @mmamas1973.bsky.social, Alaide Chieffo and Thomas LΓΌscher discuss what's to come and their vision for the future of #EAPCI.
#EAPCI26
www.tctmd.com/videos/beyon...

19.02.2026 19:33 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial cmacahilig@crf.org Thu, 02/19/2026 - 14:12 Michael O'Riordan What to make of the results remains uncertain, but experts agree that greater vigilance in low-risk patients is warranted.

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

19.02.2026 19:24 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Preview
EAPCI Summit 2026: What to Expect in Munich The inaugural event, lasting 2 days, features deep dives into technical skills, as well as new data and discussion among peers.

Today is the first day of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Summit in Munich, Germany! Get a sneak peak of what to expect from this conference. www.tctmd.com/news/eapci-s...
@mmamas1973.bsky.social
#EAPCI26 #EAPCI

19.02.2026 17:40 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Pulmonary Embolism: Studies Chart Gaps in Care but Also Progress Pulmonary Embolism: Studies Chart Gaps in Care but Also Progress cmacahilig@crf.org Thu, 02/19/2026 - 10:56 Caitlin E. Cox Women are less likely than men to receive thrombectomy. New data show the treatment can improve function and quality of life.

Pulmonary Embolism: Studies Chart Gaps in Care but Also Progress

19.02.2026 16:01 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Transfer Delays Tied to Worse Acute Stroke Intervention Results Transfer Delays Tied to Worse Acute Stroke Intervention Results cmacahilig@crf.org Wed, 02/18/2026 - 15:59 Todd Neale The study underscores the importance of door-in-door-out time as a metric associated with patient outcomes, one expert says.

Transfer Delays Tied to Worse Acute Stroke Intervention Results

18.02.2026 21:07 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
February 2026 Dispatch for the CV Team February 2026 Dispatch for the CV Team cmacahilig@crf.org Wed, 02/18/2026 - 15:35 L.A. McKeown This month: The perils of eyeballing BP logs, personalized overnight fasting gains, debating the term β€œprovider,” and more.

February 2026 Dispatch for the CV Team

18.02.2026 20:49 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Meta-analysis Teases Out What Drives Success in M-TEER By slicing and dicing the data, the study confirms MITRA-FR as an outlier and emphasizes the need for careful patient selection.

The use of M-TEER in patients with symptomatic moderate-to-severe functional mitral regurgitation reduces 24-month rates of death and hospitalization due to heart failure, based on meta-analysis from three large, randomized trials. www.tctmd.com/news/meta-an...

18.02.2026 18:18 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Video thumbnail

How will AI transform cardiology? Listen to Roxana Mehran, Ami Bhatt, and Rohan Khera discuss the technology's influence and growing adoption in the field on the latest episode of Rox Heart Radio. www.tctmd.com/audio/rox-he...

18.02.2026 15:16 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Rox Heart Radio: Why AI? Rox Heart Radio: Why AI? cmacahilig@crf.org Wed, 02/18/2026 - 09:25 3 minutes 21 seconds ago Roxana Mehran speaks with Ami Bhatt and Rohan Khera about how artificial intelligence will transform cardiology.

Rox Heart Radio: Why AI?

18.02.2026 14:30 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Why Interventionalists Must Work Toward Global Cardiovascular Equity Why Interventionalists Must Work Toward Global Cardiovascular Equity cmacahilig@crf.org Tue, 02/17/2026 - 09:54 Tesfaye Telila, MD For STEMI patients, what’s on offer hinges on geography. The remedy is small, coordinated steps to build architectures of care.

Why Interventionalists Must Work Toward Global Cardiovascular Equity

17.02.2026 15:42 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
OCEANIC-STROKE: Asundexian Prevents Recurrent Strokes, With No Added Bleeding The β€œtruly groundbreaking” results expand the tool kit for secondary stroke prevention, one expert says.

Adding asundexian to antiplatelet therapy prevents ischemic strokes in patients with acute noncardioembolic stroke or high-risk TIA without increasing bleeding, according to results from the OCEANIC-STROKE trial. More here: www.tctmd.com/news/oceanic...
#ISC2026

17.02.2026 15:09 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Industry Pays Far Less in Royalties, Consulting Fees to Female vs Male Surgeons Much of the onus for creating change should fall to the device and pharmaceutical companies themselves, one expert says.

A gender pay gap exists for female cardiothoracic surgeons, who received less money in 2023 compared with their male counterparts, according to new data. To close the gap, an expert suggests change should come from the device and pharmaceutical companies themselves. www.tctmd.com/news/industr...

16.02.2026 16:30 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 1
Post image

Miss anything from this year's two-day #CTO2026 conference in NYC? Catch up on all the content by visiting the TCTMD website. www.tctmd.com/CTO2026

16.02.2026 13:47 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis Those with preserved EF seemed to get more protection against HF events/CV death than those with reduced or unknown EF.

HF patients with diabetes, ASCVD, and/or chronic kidney disease may benefit from the use of oral GLP-1 medication, which lowers the risk of hospitalization, urgent visits, and CV death, based on data from the SOUL trial. More here: www.tctmd.com/news/oral-gl...

15.02.2026 14:05 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

It's the final day of #CTO2026! View today's presentations, and catch up on what you missed yesterday by visiting the TCTMD website. www.tctmd.com/CTO2026

14.02.2026 23:24 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
In-Hospital STEMI Patients Face Reperfusion Delays and Worse Outcomes It’s a known problem, but treatment hasn’t improved in 20 years. Experts say it’s time for protocolized systems of care.

Patients who have a ST-segment-elevation myocardial infarction while hospitalized for other conditions may face delays in reperfusion and worsening outcomes when compared with those who have a STEMI while outside the hospital, according to a new study. www.tctmd.com/news/hospita...

14.02.2026 13:59 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

It’s the final day of #CTO2026 β€” and there’s still so much left to explore!

Get a front-row seat to the latest strategies, technologies, and clinical insights.

Plan your day with the Program Guide πŸ‘‰ https://ow.ly/eA3k50Ye8Gb

#CardioSky

14.02.2026 11:00 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

Today is Day 1 of #CTO2026 in NYC! View all the slides presented at this year's conference on the TCTMD website. www.tctmd.com/CTO2026

13.02.2026 21:05 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
When Nudges Aren’t Enough: Study Ponders AS Referral System Changes When Nudges Aren’t Enough: Study Ponders AS Referral System Changes cmacahilig@crf.org Fri, 02/13/2026 - 15:15 L.A. McKeown Moving to an automatic referral for moderate or severe AS may be an option in some situations, with opt-out caveats.

When Nudges Aren’t Enough: Study Ponders AS Referral System Changes

13.02.2026 20:22 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
FASTEST Hints at Benefits of Hemostatic Therapy for Acute ICH in Select Groups Though recombinant factor VIIa didn’t improve outcomes overall, treating very early and in those with a spot sign on CT may help.

Patients with spontaneous intracerebral hemorrhage may benefit from hemostatic therapy for acute ICH when it's administered within 2 hours of onset, based on the overall FASTEST findings. www.tctmd.com/news/fastest...
#ISC2026

13.02.2026 20:00 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Adult Survivors of Childhood Cancer May Do Well With Simple Strategy for CV Risk Adult Survivors of Childhood Cancer May Do Well With Simple Strategy for CV Risk cmacahilig@crf.org Fri, 02/13/2026 - 14:25 Caitlin E. Cox A randomized study found that early screening for risk factors was as helpful as screening plus one-on-one counseling.

Adult Survivors of Childhood Cancer May Do Well With Simple Strategy for CV Risk

13.02.2026 19:33 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Video thumbnail

On this episode of Heart Valve Matters, Ami Bhatt and David Hoganson talk about computational modeling for surgical planning, exploring how 3D modeling and simulation are influencing cardiac care and surgery in young patients. www.tctmd.com/audio/pediat...

13.02.2026 19:23 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Pediatric and Congenital Heart Disease Series: Rheumatic Valve Disease Ami Bhatt and Robert Levine discuss both challenges in diagnosis and new research that will improve treatment and identify biomarkers.

Listen to Ami Bhatt and Robert Levine discuss the challenges of diagnosing rheumatic valve disease and new research that could improve treatment and identify biomarkers in the latest episode of Heart Valve Matters. www.tctmd.com/audio/pediat...

13.02.2026 18:16 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

PlanπŸ”¬ PerformπŸ’‘ Perfect 🌐 Are you ready for CTO Plus?

Share your favorite moments from the two-day gathering of CTO PCI and complex PCI pioneers with the official hashtag #CTO2026!

Plan your experience with the Program Guide πŸ‘‰ https://ow.ly/yW1k50Ye8BN

#CardioSky

12.02.2026 22:00 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

Ready to master CTO PCI and complex PCI with the masters? Make the most of your #CTO2026 πŸ«€ journey with can’t miss highlights like live cases, hands-on training, and more!

Don’t miss a beat β€” prepare with the Program Guide! πŸ‘‰ https://ow.ly/Sbtx50Ye8CZ

#CardioSky

13.02.2026 11:00 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Preview
Carotid Revascularization Doesn’t Improve Cognition: CREST-2 Neither stenting nor endarterectomy provided a boost versus medical therapy alone in patients with asymptomatic stenosis.

Carotid revascularization with either stenting or endarterectomy doesn't improve cognitive function in patients who have asymptomatic high-grade carotid artery stenosis, according to data from the CREST-2 trial. More here: www.tctmd.com/news/carotid...
#ISC2026

12.02.2026 20:14 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Have you caught the latest episode of Hearts & Minds yet? Listen to @yaelmaxwell.bsky.social talk to Mario Gaudino as he discusses everything from transforming clinical and research paradigms to how his pet bunny Koni almost sabotaged one of his trials! www.tctmd.com/audio/2-mari...

12.02.2026 18:11 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Side Effects of Statins Might Be Overstated: CTT Collaboration Side Effects of Statins Might Be Overstated: CTT Collaboration cmacahilig@crf.org Thu, 02/12/2026 - 11:56 Michael O'Riordan Statin labels should be revised to reflect their safety and to hopefully spur better uptake and adherence, say experts.

Side Effects of Statins Might Be Overstated: CTT Collaboration

12.02.2026 17:05 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

@tctmd is following 20 prominent accounts